These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33594116)

  • 1. Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma.
    Hu LS; Wang L; Hawkins-Daarud A; Eschbacher JM; Singleton KW; Jackson PR; Clark-Swanson K; Sereduk CP; Peng S; Wang P; Wang J; Baxter LC; Smith KA; Mazza GL; Stokes AM; Bendok BR; Zimmerman RS; Krishna C; Porter AB; Mrugala MM; Hoxworth JM; Wu T; Tran NL; Swanson KR; Li J
    Sci Rep; 2021 Feb; 11(1):3932. PubMed ID: 33594116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Baxter LC; Gaw N; Ranjbar S; Plasencia J; Dueck AC; Peng S; Smith KA; Nakaji P; Karis JP; Quarles CC; Wu T; Loftus JC; Jenkins RB; Sicotte H; Kollmeyer TM; O'Neill BP; Elmquist W; Hoxworth JM; Frakes D; Sarkaria J; Swanson KR; Tran NL; Li J; Mitchell JR
    Neuro Oncol; 2017 Jan; 19(1):128-137. PubMed ID: 27502248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    Wang L; Wang H; D'Angelo F; Curtin L; Sereduk CP; Leon G; Singleton KW; Urcuyo J; Hawkins-Daarud A; Jackson PR; Krishna C; Zimmerman RS; Patra DP; Bendok BR; Smith KA; Nakaji P; Donev K; Baxter LC; Mrugała MM; Ceccarelli M; Iavarone A; Swanson KR; Tran NL; Hu LS; Li J
    PLoS One; 2024; 19(4):e0299267. PubMed ID: 38568950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
    Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
    J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting epidermal growth factor receptor gene amplification status in glioblastoma multiforme by quantitative enhancement and necrosis features deriving from conventional magnetic resonance imaging.
    Dong F; Zeng Q; Jiang B; Yu X; Wang W; Xu J; Yu J; Li Q; Zhang M
    Medicine (Baltimore); 2018 May; 97(21):e10833. PubMed ID: 29794775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive O
    Hajianfar G; Shiri I; Maleki H; Oveisi N; Haghparast A; Abdollahi H; Oveisi M
    World Neurosurg; 2019 Dec; 132():e140-e161. PubMed ID: 31505292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative model based on clinically relevant MRI features differentiates lower grade gliomas and glioblastoma.
    Cao H; Erson-Omay EZ; Li X; Günel M; Moliterno J; Fulbright RK
    Eur Radiol; 2020 Jun; 30(6):3073-3082. PubMed ID: 32025832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
    Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
    J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.
    Fathi Kazerooni A; Bakas S; Saligheh Rad H; Davatzikos C
    J Magn Reson Imaging; 2020 Jul; 52(1):54-69. PubMed ID: 31456318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics for precision medicine in glioblastoma.
    Aftab K; Aamir FB; Mallick S; Mubarak F; Pope WB; Mikkelsen T; Rock JP; Enam SA
    J Neurooncol; 2022 Jan; 156(2):217-231. PubMed ID: 35020109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of intratumoral heterogeneity in high-grade glioma.
    Hu LS; Hawkins-Daarud A; Wang L; Li J; Swanson KR
    Cancer Lett; 2020 May; 477():97-106. PubMed ID: 32112907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.
    Binder ZA; Thorne AH; Bakas S; Wileyto EP; Bilello M; Akbari H; Rathore S; Ha SM; Zhang L; Ferguson CJ; Dahiya S; Bi WL; Reardon DA; Idbaih A; Felsberg J; Hentschel B; Weller M; Bagley SJ; Morrissette JJD; Nasrallah MP; Ma J; Zanca C; Scott AM; Orellana L; Davatzikos C; Furnari FB; O'Rourke DM
    Cancer Cell; 2018 Jul; 34(1):163-177.e7. PubMed ID: 29990498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiogenomic analysis of PTEN mutation in glioblastoma using preoperative multi-parametric magnetic resonance imaging.
    Li Y; Liang Y; Sun Z; Xu K; Fan X; Li S; Zhang Z; Jiang T; Liu X; Wang Y
    Neuroradiology; 2019 Nov; 61(11):1229-1237. PubMed ID: 31218383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment: Radiogenomics of glioblastoma: shifting the focus from tumor cells to immune microenvironment.
    Politi LS; Levi R
    Eur Radiol; 2023 Jan; 33(1):207-208. PubMed ID: 36305901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI.
    Gaw N; Hawkins-Daarud A; Hu LS; Yoon H; Wang L; Xu Y; Jackson PR; Singleton KW; Baxter LC; Eschbacher J; Gonzales A; Nespodzany A; Smith K; Nakaji P; Mitchell JR; Wu T; Swanson KR; Li J
    Sci Rep; 2019 Jul; 9(1):10063. PubMed ID: 31296889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging genomics of Glioblastoma: state of the art bridge between genomics and neuroradiology.
    ElBanan MG; Amer AM; Zinn PO; Colen RR
    Neuroimaging Clin N Am; 2015 Feb; 25(1):141-53. PubMed ID: 25476518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.